The Food and Drug Administration (FDA) on Wednesday authorized booster shots for Moderna and Johnson & Johnson vaccines for certain eligible populations, adding that people can take a different vaccine brand than the ones they’d taken originally. The booster campaign for those aged 65 and over and those at high risk aims to increase protection against COVID-19 amid signs that vaccine efficacy decreases over time. “Today the currently available data suggest waning immunity in some populations of fully vaccinated people,” FDA’s acting commissioner Janet Woodcock said. “The availability of these authorized boosters is important for continued protection against COVID-19 disease.” The FDA on Wednesday authorized a third COVID-19 vaccine dose from Moderna for seniors and those at risk of severe disease, and those who may be exposed at their residence or work to the CCP (Chinese Communist Party) virus. The booster is authorized six months after a person’s last inoculation and will …